Survival Outcomes in Different Sino-nasal Malignancies: An Institutional Review

Author:

Preetha Umesh1ORCID,Akhter Shamima1,Sarthak Tandon1,Parveen Ahlawat1,Sandeep Purohit1ORCID,Munish Gairola1

Affiliation:

1. Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, Delhi, India
2Department of Obstetrics and Gynecology, CIMC, Bangladesh

Abstract

Objective: The purpose of this review is to comprehend the treatment outcome of different PNS cancer histologies and their survival. Materials and Procedures: A review of our institutional database from January 2010 to December 2022 included 122 sinonasal cancer patients. After exclusions, 84 patients whose data sets were complete underwent analysis. Overall survival (OS), loco-regional failure-free survival (LRFS), and distant metastases-free survival (DMFS) were the measured endpoints. Results: With a median follow-up time of 26 months, there was no correlation detected between histological type and OS, LRFS, or DMFS. It was discovered that the type of treatment technique was substantially related to LRFS. Surgery plus adjuvant radiation and/or chemotherapy had a minor tendency to be significant in terms of OS, with a median OS of 56 months (95% CI: 38.6–73.3). Conclusions: It showed that the use of different treatment modalities had an impact on LRFS, while the type of histology did not correlate with the effectiveness of the treatment.

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3